Immunotech Biopharm Ltd Engages in Strategic Financial Investment
I'm PortAI, I can summarize articles.
Immunotech Biopharm Ltd announced a discloseable transaction involving a RMB120 million investment in structured deposit products from Bank of China Limited. This strategic financial move aims to manage financial assets effectively and enhance returns. The announcement complies with Listing Rules requirements.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments